Related Experiment Video
Updated: May 24, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
[Analysis of curative effect for 21 recurrent soft-tissue sarcoma].
Zhen-feng Li1, Jian-min Li, Zhi-ping Yang
1Department of Orthopaedics Surgery, Qilu Hospital of Shandong University, Jinan 250012, China.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|February 16, 2012
Summary
Surgery for recurrent soft-tissue sarcoma requires adequate margins to prevent local recurrence. Complete tumor removal combined with radiation and chemotherapy is crucial for successful treatment outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Sarcoma Research
Context:
- Recurrent soft-tissue sarcoma presents a significant clinical challenge.
- Effective treatment strategies are essential for improving patient prognosis.
Purpose:
- To evaluate surgical outcomes for recurrent soft-tissue sarcoma.
- To assess the efficacy of different surgical approaches and adjuvant therapies.
Summary:
- Analysis of 21 recurrent soft-tissue sarcoma cases treated between 2005 and 2011.
- Surgical interventions included amputation, wide resection, and marginal excision.
- Outcomes varied, with some patients experiencing recurrence, metastasis, or mortality, while others lived with residual disease.
Impact:
- Highlights the importance of achieving adequate surgical margins to minimize local recurrence.
- Emphasizes the necessity of complete tumor eradication and multimodal treatment (radiation, chemotherapy) for recurrent soft-tissue sarcomas.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...